Structure’s Oral Weight Loss Drug Data Underperforms A Big Rival

 
• By Jessica Merrill
tape measure
Investors weren't sure Structure's Phase II data measures up to Lilly's • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapeutic Category